Pfizer-BioNTech Ask FDA for Full Approval of COVID-19 Vaccine

Pfizer-BioNTech Ask FDA for Full Approval of COVID-19 Vaccine

Pfizer-BioNTech announced on May 7 that they have requested that the U.S. Food and Drug Administration (FDA) start the process of fully approving their COVID-19 vaccine. The FDA issued an emergency use authorization for the shot in December, based on short-term data on safety and efficacy. What difference would approval of the vaccine make over the current authorization? “Full approval would put those concerns and disinformation to rest.”For people who have already been vaccinated, the filing and anticipated approval doesn’t make much difference. Having an approved product also lets the companies sell their vaccine directly to doctors, hospitals, pharmacies, schools and other places that provide immunizations.

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!